Molecular docking study of anticancer activity of some s-triazine derivatives as HDAC6 inhibitors

A novel series of s-triazine derivatives was designed and screened for in silico an cancer activity in histone deacetylase 6 (HDAC6) target by molecular docking method using AutoDock Vina.